{"brief_title": "Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)", "brief_summary": "The purpose of this study is to evaluate the long-term safety of an investigational drug versus an approved drug for the relief of pain in patients with rheumatoid arthritis.", "detailed_description": "The duration of treatment is 12 months.", "condition": ["Rheumatoid Arthritis"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["MK0663, etoricoxib", "Comparator: Diclofenac sodium"], "criteria": "Inclusion Criteria: - Males and females 50 years or older with rheumatoid arthritis. Exclusion Criteria: - History of gastrointestinal malabsorption or inflammatory bowel disease - History of heart problems such as: congestive heart failure (CHF), heart attack or high blood pressure.", "gender": "All", "minimum_age": "50 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Arcoxia", "mesh_term": ["Arthritis", "Arthritis, Rheumatoid", "Diclofenac", "Etoricoxib"], "id": "NCT00092742"}